HR 5385
106th Congress
House
RU-486 Patient Health and Safety Protection Act
Official title: To require the Food and Drug Administration to establish restrictions regarding the qualifications of physicians to prescribe the abortion drug commonly known as RU-486.
Health
AbortionAdministrative procedureContinuing educationCurricula
More subjectsShow fewer subjects
Department of Health and Human ServicesDrug approvalsEducationGovernment Operations and PoliticsHigher educationHospital medical staffImaging systems in medicineLawMedical educationMedical testsPhysiciansPregnancyRU 486 (Drug)Transportation and Public WorksTravelWomen
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 20, 2000
Referred to the Subcommittee on Health and Environment.
Oct 4, 2000
Referred to the House Committee on Commerce.
Oct 4, 2000
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health and Environment.
Plain-English summary
RU-486 Patient Health and Safety Protection Act - Restricts the prescribing of the drug mifepristone (commonly referred to as RU-486, to be marketed as Mifeprex) to physicians who meet specified requirements.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 5385: RU-486 Patient Health and Safety Protection Act. 106th Congress. Open America. https://openamerica.io/bill/106-HR-5385/
"H.R. 5385: RU-486 Patient Health and Safety Protection Act." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-5385/.
H.R. 5385, 106th Cong. (2026), https://openamerica.io/bill/106-HR-5385/.
[H.R. 5385: RU-486 Patient Health and Safety Protection Act](https://openamerica.io/bill/106-HR-5385/)